There were also other studies that demonstrated the overexpression of PARP1 in prostate carcinoma, colorectal carcinoma, pediatric central nervous system carcinomas, and testicular germ cell tumors, respectively [31,32,33,34] (Table 1). The gene discussed is PARP1; the disease is prostate carcinoma.